NCT01602406 · Interventional trial
Phase I Study LJM716 Combined With Trastuzumab in Patients With HER2 Overexpressing Metastatic Breast or Gastric Cancer
Overall registry status Completed
Phase 1
Conditions Advanced HER2-positive Breast Cancer or Gastric Cancer
Delaware Valley sites
- Novartis Investigative Site · Philadelphia, PA · Philadelphia County
First posted
Registry updated
Added to the directory